BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim M, Jo Y, Hwang YJ, Hong HW, Hong SS, Park K, Myung H. Phage-Antibiotic Synergy via Delayed Lysis. Appl Environ Microbiol 2018;84:e02085-18. [PMID: 30217844 DOI: 10.1128/AEM.02085-18] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Mitropoulou G, Koutsokera A, Csajka C, Blanchon S, Sauty A, Brunet JF, von Garnier C, Resch G, Guery B. Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations. Eur Respir Rev 2022;31:220121. [PMID: 36198417 DOI: 10.1183/16000617.0121-2022] [Reference Citation Analysis]
2 Rendueles C, Escobedo S, Rodríguez A, Martínez B. Bacteriocin-phage interaction (BaPI): Phage predation of Lactococcus in the presence of bacteriocins. Microbiologyopen 2022;11:e1308. [PMID: 36031956 DOI: 10.1002/mbo3.1308] [Reference Citation Analysis]
3 Diallo K, Dublanchet A. Benefits of Combined Phage–Antibiotic Therapy for the Control of Antibiotic-Resistant Bacteria: A Literature Review. Antibiotics 2022;11:839. [DOI: 10.3390/antibiotics11070839] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Chang RYK, Nang SC, Chan HK, Li J. Novel antimicrobial agents for combating antibiotic-resistant bacteria. Adv Drug Deliv Rev 2022;187:114378. [PMID: 35671882 DOI: 10.1016/j.addr.2022.114378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chiș AA, Rus LL, Morgovan C, Arseniu AM, Frum A, Vonica-țincu AL, Gligor FG, Mureșan ML, Dobrea CM. Microbial Resistance to Antibiotics and Effective Antibiotherapy. Biomedicines 2022;10:1121. [DOI: 10.3390/biomedicines10051121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Liu C, Hong Q, Chang RYK, Kwok PCL, Chan H. Phage–Antibiotic Therapy as a Promising Strategy to Combat Multidrug-Resistant Infections and to Enhance Antimicrobial Efficiency. Antibiotics 2022;11:570. [DOI: 10.3390/antibiotics11050570] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
7 Liu R, Han G, Li Z, Cun S, Hao B, Zhang J, Liu X. Bacteriophage therapy in aquaculture: current status and future challenges. Folia Microbiol (Praha) 2022. [PMID: 35305247 DOI: 10.1007/s12223-022-00965-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Türe M, Cebeci A, Aygür E, Balcı F, Çalışkan N, Polat E. Effect of Antibiotics and Glycerol on Improving Bacteriophage Detection and Enumeration. Bulletin of the European Association of Fish Pathologists 2022. [DOI: 10.48045/001c.37068] [Reference Citation Analysis]
9 Finney AG, Perry JM, Evans DR, Westbrook KJ, Mcelheny CL, Iovleva A, Doi Y, Shields RK, Van Tyne D. Isolation and Characterization of Lytic Bacteriophages Targeting Diverse Enterobacter spp. Clinical Isolates. PHAGE 2022;3:50-8. [DOI: 10.1089/phage.2021.0011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Farooq T, Hussain MD, Shakeel MT, Tariqjaveed M, Aslam MN, Naqvi SAH, Amjad R, Tang Y, She X, He Z. Deploying Viruses against Phytobacteria: Potential Use of Phage Cocktails as a Multifaceted Approach to Combat Resistant Bacterial Plant Pathogens. Viruses 2022;14:171. [DOI: 10.3390/v14020171] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Ma D, Li L, Han K, Wang L, Cao Y, Zhou Y, Chen H, Wang X. The antagonistic interactions between a polyvalent phage SaP7 and β-lactam antibiotics on combined therapies. Vet Microbiol 2022;266:109332. [PMID: 35033842 DOI: 10.1016/j.vetmic.2022.109332] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Meah I, Singleton DR. A novel Hafnia-specific bacteriophage is capable of transduction of ampicillin resistance between bacterial species. Journal of the Pennsylvania Academy of Science 2021;95:88-103. [DOI: 10.5325/jpennacadscie.95.2.0088] [Reference Citation Analysis]
13 Attrill EL, Claydon R, Łapińska U, Recker M, Meaden S, Brown AT, Westra ER, Harding SV, Pagliara S. Individual bacteria in structured environments rely on phenotypic resistance to phage. PLoS Biol 2021;19:e3001406. [PMID: 34637438 DOI: 10.1371/journal.pbio.3001406] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
14 Li X, He Y, Wang Z, Wei J, Hu T, Si J, Tao G, Zhang L, Xie L, Abdalla AE, Wang G, Li Y, Teng T. A combination therapy of Phages and Antibiotics: Two is better than one. Int J Biol Sci 2021;17:3573-82. [PMID: 34512166 DOI: 10.7150/ijbs.60551] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 19.0] [Reference Citation Analysis]
15 Horiuk YV, Kukhtyn MD, Horiuk VV, Sytnik VA, Dashkovskyy OO. Effect of Phage SAvB14 combined with antibiotics on Staphylococcus aureus variant bovis. Regul Mech Biosyst 2021;12:531-6. [DOI: 10.15421/022173] [Reference Citation Analysis]
16 Duplessis C, Warawa JM, Lawrenz MB, Henry M, Biswas B. Successful Intratracheal Treatment of Phage and Antibiotic Combination Therapy of a Multi-Drug Resistant Pseudomonas aeruginosa Murine Model. Antibiotics (Basel) 2021;10:946. [PMID: 34438996 DOI: 10.3390/antibiotics10080946] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Lauman P, Dennis JJ. Advances in Phage Therapy: Targeting the Burkholderia cepacia Complex. Viruses 2021;13:1331. [PMID: 34372537 DOI: 10.3390/v13071331] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
18 Shah M, Murad W, Ur Rehman N, Halim SA, Ahmed M, Rehman H, Zahoor M, Mubin S, Khan A, Nassan MA, Batiha GE, Al-Harrasi A. Biomedical Applications of Scutellaria edelbergii Rech. f.: In Vitro and In Vivo Approach. Molecules 2021;26:3740. [PMID: 34205312 DOI: 10.3390/molecules26123740] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
19 Giacometti F, Shirzad-Aski H, Ferreira S. Antimicrobials and Food-Related Stresses as Selective Factors for Antibiotic Resistance along the Farm to Fork Continuum. Antibiotics (Basel) 2021;10:671. [PMID: 34199740 DOI: 10.3390/antibiotics10060671] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
20 Li X, Hu T, Wei J, He Y, Abdalla AE, Wang G, Li Y, Teng T. Characterization of a Novel Bacteriophage Henu2 and Evaluation of the Synergistic Antibacterial Activity of Phage-Antibiotics. Antibiotics (Basel) 2021;10:174. [PMID: 33572473 DOI: 10.3390/antibiotics10020174] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
21 Davis CM, McCutcheon JG, Dennis JJ. Aztreonam Lysine Increases the Activity of Phages E79 and phiKZ against Pseudomonas aeruginosa PA01. Microorganisms 2021;9:152. [PMID: 33445453 DOI: 10.3390/microorganisms9010152] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
22 Misol GN Jr, Kokkari C, Katharios P. Biological and Genomic Characterization of a Novel Jumbo Bacteriophage, vB_VhaM_pir03 with Broad Host Lytic Activity against Vibrio harveyi. Pathogens 2020;9:E1051. [PMID: 33333990 DOI: 10.3390/pathogens9121051] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
23 Kalapala YC, Sharma PR, Agarwal R. Antimycobacterial Potential of Mycobacteriophage Under Disease-Mimicking Conditions. Front Microbiol 2020;11:583661. [PMID: 33381088 DOI: 10.3389/fmicb.2020.583661] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
24 Prudêncio C, Vieira M, Van der Auweraer S, Ferraz R. Recycling Old Antibiotics with Ionic Liquids. Antibiotics (Basel) 2020;9:E578. [PMID: 32899785 DOI: 10.3390/antibiotics9090578] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
25 Luscher A, Simonin J, Falconnet L, Valot B, Hocquet D, Chanson M, Resch G, Köhler T, van Delden C. Combined Bacteriophage and Antibiotic Treatment Prevents Pseudomonas aeruginosa Infection of Wild Type and cftr- Epithelial Cells. Front Microbiol 2020;11:1947. [PMID: 32983005 DOI: 10.3389/fmicb.2020.01947] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
26 Gu Liu C, Green SI, Min L, Clark JR, Salazar KC, Terwilliger AL, Kaplan HB, Trautner BW, Ramig RF, Maresso AW. Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry. mBio 2020;11:e01462-20. [PMID: 32753497 DOI: 10.1128/mBio.01462-20] [Cited by in Crossref: 71] [Cited by in F6Publishing: 86] [Article Influence: 35.5] [Reference Citation Analysis]
27 Meah I, Singleton D. Instrumentation & Investigation of Phage-Antibiotic Synergy on K. pneumoniae, H. alvei, and Transductant H. alvei. 2020 IEEE Integrated STEM Education Conference (ISEC) 2020. [DOI: 10.1109/isec49744.2020.9397809] [Reference Citation Analysis]
28 de Miguel T, Rama JLR, Sieiro C, Sánchez S, Villa TG. Bacteriophages and Lysins as Possible Alternatives to Treat Antibiotic-Resistant Urinary Tract Infections. Antibiotics (Basel) 2020;9:E466. [PMID: 32751681 DOI: 10.3390/antibiotics9080466] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
29 Loessner H, Schlattmeier I, Anders-Maurer M, Bekeredjian-Ding I, Rohde C, Wittmann J, Pokalyuk C, Krut O, Kamp C. Kinetic Fingerprinting Links Bacteria-Phage Interactions with Emergent Dynamics: Rapid Depletion of Klebsiella pneumoniae Indicates Phage Synergy. Antibiotics (Basel) 2020;9:E408. [PMID: 32674401 DOI: 10.3390/antibiotics9070408] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
30 Duplessis CA, Biswas B. A Review of Topical Phage Therapy for Chronically Infected Wounds and Preparations for a Randomized Adaptive Clinical Trial Evaluating Topical Phage Therapy in Chronically Infected Diabetic Foot Ulcers. Antibiotics (Basel) 2020;9:E377. [PMID: 32635429 DOI: 10.3390/antibiotics9070377] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
31 Manohar P, Loh B, Athira S, Nachimuthu R, Hua X, Welburn SC, Leptihn S. Secondary Bacterial Infections During Pulmonary Viral Disease: Phage Therapeutics as Alternatives to Antibiotics? Front Microbiol 2020;11:1434. [PMID: 32733404 DOI: 10.3389/fmicb.2020.01434] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 20.5] [Reference Citation Analysis]
32 Zuo P, Yu P, Alvarez PJJ. Beta-lactam-Induced Outer Membrane Alteration Confers E. coli a Fortuitous Competitive Advantage through Cross-Resistance to Bacteriophages. Environ Sci Technol Lett 2020;7:428-33. [DOI: 10.1021/acs.estlett.0c00318] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
33 Kalapala YC, Sharma PR, Agarwal R. Antimycobacterial potential of Mycobacteriophage under disease-mimicking conditions.. [DOI: 10.1101/2020.05.16.100123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Nikolich MP, Filippov AA. Bacteriophage Therapy: Developments and Directions. Antibiotics (Basel) 2020;9:E135. [PMID: 32213955 DOI: 10.3390/antibiotics9030135] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 19.5] [Reference Citation Analysis]
35 Moura de Sousa JA, Buffet A, Haudiquet M, Rocha EP, Rendueles O. Modular prophage interactions driven by capsule serotype select for capsule loss under phage predation.. [DOI: 10.1101/2019.12.17.878363] [Reference Citation Analysis]
36 Caflisch KM, Suh GA, Patel R. Biological challenges of phage therapy and proposed solutions: a literature review. Expert Rev Anti Infect Ther 2019;17:1011-41. [PMID: 31735090 DOI: 10.1080/14787210.2019.1694905] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 9.3] [Reference Citation Analysis]
37 Clifton SM, Kim T, Chandrashekhar JH, O'Toole GA, Rapti Z, Whitaker RJ. Lying in Wait: Modeling the Control of Bacterial Infections via Antibiotic-Induced Proviruses. mSystems 2019;4:e00221-19. [PMID: 31575664 DOI: 10.1128/mSystems.00221-19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
38 Malik S, Sidhu PK, Rana JS, Nehra K. Managing urinary tract infections through phage therapy: a novel approach. Folia Microbiol (Praha) 2020;65:217-31. [PMID: 31494814 DOI: 10.1007/s12223-019-00750-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
39 Knezevic P, Aleksic Sabo V. Combining Bacteriophages with Other Antibacterial Agents to Combat Bacteria. Phage Therapy: A Practical Approach 2019. [DOI: 10.1007/978-3-030-26736-0_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]